Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)

NCT00120757 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

140

Enrollment

OTHER_GOV

Sponsor class

Conditions

Osteoporosis
HIV Infections

Interventions

DRUG: Alendronate

Sponsor

French National Agency for Research on AIDS and Viral Hepatitis